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Abstract  Following  interventional  radiology  procedures,  bleeding  can  occur  in  0.5  to  4%  of
the cases.  Risk  factors  are  related  to  the  patient,  to  the  procedure,  and  to  the  end  organ.
Bleeding is  treated  usually  by  interventional  radiologists  and  consists  mainly  of  embolization.
Bleeding  complications  are  preventable:  before  the  procedure  by  checking  hemostasis,  during
the procedure  by  ensuring  the  accurate  puncture  site  (with  ultrasound  or  ﬂuoroscopy  guid-
ance) or  by  treating  the  puncture  path  using  gelatin  sponge,  curaspon®,  biological  glue  or
thermocoagulation,  and  after  the  procedure  by  carefully  monitoring  the  patients.© 2015  Éditions  franc¸aises  de  radiologie.  Published  by  Elsevier  Masson  SAS.  All  rights  reserved.
With  the  development  of  interventional  radiology  in  the  ﬁeld  of  oncology,  bleeding
complications  have  been  observed.  The  incidence  of  vascular  complications  is  between
0.5  and  4%,  regardless  whether  the  access  is  percutaneous  or  intravascular  [1—3].
It  is  therefore  important  to  know  what  the  risk  factors  of  post-interventional  radiology
bleeding  are,  where  the  bleeding  sites  are  depending  on  the  procedures,  how  to  treat  the
bleeding  and  how  to  prevent  it.
The  goal  of  this  review  was  threefold.  First,  we  wished  to  analyze  the  different  risk
factors  related  to  the  patient,  to  the  procedure,  the  lesion  and  the  end  organ.  Second,  we
wanted  to  report  the  different  types  of  bleeding,  based  on  the  intravascular  and  percu-
taneous  access,  and  how  to  treat  them.  Third,  we  aimed  to  discuss  how  the  bleeding  risk
can  be  anticipated  and  thus  minimized  using  biological  tests,  ultrasound-guided  puncture
and  percutaneous  closure  devices.
∗ Corresponding author.
E-mail address: jolymay@hotmail.com (J. Mayer).
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it  is  possible  to  treat  it  with  coils  (Fig.  2)  and  also  to
place  coils,  according  to  the  ‘‘sandwich’’  technique,  dis-34  
isk factors
isk  factors  are  listed  in  Table  1.
atient-related risks
ome  of  the  risk  factors  are  observed  with  the  arterial  access
oute:  patients  over  the  age  of  65  years,  women,  patients
t  risk  for  cardiovascular  disease  (atherosclerosis,  obesity,
iabetes,  arterial  hypertension)  and  chronic  renal  failure.
Other  risk  factors  are  observed  with  both  percutaneous
nd  intravascular  access  routes:  blood  coagulation  disorders
nd  the  use  of  anticoagulant  and  antiplatelet  agents.
rocedure-related risks
n  case  of  arterial  access,  complex  and  long  procedures  are
isk  factors  for  complications.  Additional  risk  factors  are  the
umber  of  punctures,  an  inappropriate  puncture  site  as  well
s  a  size  of  sheath  introducer  larger  than  6  French.  For  com-
on  femoral  punctures,  a  puncture  site  too  high  (above  the
nguinal  ligament,  i.e.  external  iliac  artery)  increases  the
isk  of  retroperitoneal  hematomas  while  a  puncture  site  too
ow  (superﬁcial  or  even  profunda  femoral  artery)  increases
he  risk  of  pseudoaneurysms.  We  will  look  at  the  methods
vailable  to  improve  arterial  punctures  [1—3].
A  retrospective  study  including  9861  coronary  interven-
ions  carried  out  by  the  New  York  Presbyterian/Columbia
niversity  Medical  Center  reported  the  following  signiﬁcant
isk  factors:  patient’s  age  above  70  years,  chronic  renal  fail-
re,  the  size  of  the  introducer  sheath  (French  size  above
),  manual  compression  of  the  puncture  site  rather  than  a
ercutaneous  closure  system  and  a  long  procedure  (longer
han  1 hour)  [4].  We  will  further  discuss  the  use  of  percu-
aneous  closure  devices  below  when  we’ll  discuss  how  to
educe  bleeding  complications.
In  case  of  percutaneous  access,  the  size  of  the  needle
higher  than  18  gauge)  and  the  number  of  punctures  are  risk
actors  [3].
umor- and end organ-related risks
ypervascular  tumors  may  be  predictive  of  complications,
lthough  this  is  still  debated.  In  case  of  subcapsular  involve-
ent,  the  risk  of  bleeding  is  increased.  Kidney  and  a
irrhotic  liver  also  are  risk  factors  for  bleeding.  Finally,
scites  is  also  a  risk  factor  [3].
Table  1  Bleeding  risk  factors  during  procedures  in  interventio
Patient-related  Procedure-related  
Over  the  age  of  65
Female
Cardiovascular  risk  factors
Chronic  renal  failure
Hemostasis  disorders
Anticoagulant/antiplatelet  treatment
Complexity/duratio
Number  of  puncture
Inaccurate  site  of  p
Introducer  size  abov
Needle  size  above  1
t
rJ.  Mayer  et  al.
ifferent types of bleeding
leeding during a percutaneous puncture or
adiofrequency ablation
t  the  end  of  a  procedure,  blood  may  ﬂow  through  the
oaxial  during  the  removal  of  the  biopsy  or  radiofrequency
blation  needle.  It  is  possible  to  dab  the  blood  with  the
oam  tip  of  a  biopsy  needle  that  can  sometimes  be  found
n  the  biopsy  set,  or  to  push  gelita-spon® (biodegradable
mbolization  material)  into  the  coaxial.  It  is  possible  to  cut
mall  strips  of  gelita-spon® and  to  push  them  towards  the
ite  with  a  syringe  of  sterile  water  or  with  the  needle  used
or  the  biopsy  or  the  radiofrequency  ablation.  Some  experts,
nstead,  use  biological  glue  that  has  the  advantage  to  mark
he  lesion  [3].
Finally,  some  experts  recommend  to  thermocoagulate
he  needle  track  after  a  radiofrequency  ablation,  although
hether  this  decreases  the  bleeding  risk  remains  a  matter
f  debate.
leeding during endovascular procedure
hepatic chemoembolization)
uring  an  interventional  radiology  procedure  in  oncology,
omplications  such  as  pseudoaneurysms  or  extravasation  of
ontrast  medium  may  be  observed.  It  is  possible  to  treat
hese  complications  (coil  embolization  or  curaspon® gelatin
ponge)  (Fig.  1)  and  to  continue  the  procedure  depend-
ng  on  the  hemodynamic  state  of  the  patient.  Indeed,  the
rterial  vessels  of  oncology  patients  may  have  become
eaker  by  the  different  treatments  (chemotherapy  includ-
ng  Sorafenib)  [5]  and  by  repeated  endovascular  procedures
6].
leeding after biopsy or radiofrequency
blation
fter  a  biopsy  or  a  radiofrequency  ablation,  pain  and  even
cute  bleeding  may  be  observed.  An  enhanced  scan  obtained
t  arterial  and  venous  phases  can  detect  a  possible  pseu-
oaneurysm  or  active  bleeding,  which  will  be  treated  by
ndovascular  embolization.  In  case  of  a  pseudoaneurysm,nal  radiology.
Tumor-  and  organ-related
n  of  procedure
s
uncture
e  6F
8G
Hypervascular  tumor  (under  debate)
Subcapsular  location
Kidney
Cirrhotic  liver
Ascites
al  and  proximal  to  the  aneurysm  neck,  thereby  avoiding
e-bleeding  [7].
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Figure 1. Arteriography during liver chemoembolization through the superior mesenteric and gastroduodenal arteries (origin of the celiac
trunk occluded) showing an active bleeding of the catheterized branch (a: white arrow); important active bleeding of the catheterized
branch (b: white arrow); bleeding treated by coils (c: white arrow); catheterization of the gastroduodenal artery by another branch and
P
t
mchemoembolization (d: white arrows).
Complications at arterial puncture site
(femoral)A  complication  (hematoma  or  pseudoaneurysm)  at  the  arte-
rial  puncture  site  is  diagnosed  by  arterial  ultrasound  Doppler
or  by  CT  scan  with  injection  of  contrast  medium  (Fig.  3).
n
a
c
Figure 2. Arteriography showing a post-biopsy hepatic pseudoaneury
pseudoaneurysm with a microcatheter (b: white arrow); endovascular trseudoaneurysms  smaller  than  2  cm  often  thrombose  spon-
aneously.  The  treatment  for  these  pseudoaneurysms  is
anual  compression,  possibly  ultrasound-guided.  Pseudoa-
eurysms  above  the  size  of  2  cm  usually  require  surgery,
lthough  they  are  increasingly  treated  by  endovascular  pro-
edure  [2].
sm (a: white arrow); catheterization of the arterial feeder of the
eatment of the pseudoaneurysm with coils (c: white arrow).
836  J.  Mayer  et  al.
Figure 3. CT scan with injection of contrast medium at arterial (a) and venous phases (b), in an oblique coronal plane and MIP recon-
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atruction, showing a pseudoaneurysm of the right superﬁcial femor
reatment of pseudoaneurysm at puncture
ite
raditional treatment: surgery
he  indications  for  surgical  treatment  of  the  Scarpa  pseu-
oaneurysm  are  the  following:  rapidly  expansive  hematoma,
nfected  pseudoaneurysm,  nerve  compression,  ischemia,  or
nstable  hemodynamic  patient  [2].  Treatment  is  by  femoral
pproach  (Scarpa)  and  surgical  suture  of  the  pseudoa-
eurysm  neck  [8].
ndovascular treatment by direct puncture
hrombin  injection:  the  pseudoaneurysm  is  visualized  under
ltrasound,  and  the  distance  between  the  skin  and  the
uperﬁcial  portion  of  the  pseudoaneurysm  is  measured.
hen,  local  anesthesia  is  applied,  and  we  use  the  ‘‘three-
ay  stopcock’’  technique:  2  syringes  with  a  three-way
topcock.  One  syringe  contains  sodium  chloride  and  the
ther  the  prepared  thrombin.  The  puncture  to  the  pseudoa-
eurysm  cavity  is  ultrasound-guided,  with  slow  aspiration
f  NaCl  until  getting  blood  in  the  syringe.  Then,  with  slow
njection  of  thrombin  far  of  the  pseudoaneurysm  neck,  with
liquots  of  0.2  mL  up  to  a  maximum  of  1  mL.  Common,  super-
cial  and  profunda  femoral  arteries  must  be  checked  for
bsence  of  embolization.  The  pseudoaneurysm  is  assessed
y  Doppler  after  24  to  72  hours,  and  it  is  always  possible  to
e-inject  thrombin  [2].  Rare  complications  such  as  embolic
arterial  or  pulmonary)  complications,  vasovagal,  infectious
nd  allergic  reactions  have  been  reported  [2].
Injection  of  coils  by  direct  puncture:  since  thrombin
as  prohibited  in  the  1990s  (Creutzfeldt  Jacob  disease),
obeiter  et  al.  tried  to  inject  coils  instead  of  thrombin.  The
eries  of  patients  was  small,  16,  but  the  primary  success  rate
eached  88%  [9].
Injection  of  a  saline/lidocaine  (0.2%)  solution:  in  a  series
f  11  patients,  Périard  et  al.  successfully  injected  the  solu-
ion  around  the  narrow  neck  of  the  pseudo-aneurysm.  This
as  followed  by  a  short  echo-guided  compression  [10].
p
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w
p
Aery (white arrow) (femoral puncture too low).
ndovascular catheterization by coils and
tents
oil  embolization  (Fig.  4):  this  technique  requires  contralat-
ral  puncture  and  crossover.  An  arteriography  visualizes  the
seudoaneurysm  and  its  neck.  The  catheter  is  positioned
n  front  of  the  neck  (stability  is  improved  by  the  use  of
 long  introducer)  and  the  neck  is  catheterized  with  a
icrocatheter.  Microcoils  are  inserted.  At  the  end  of  the
rocedure,  the  absence  of  pseudoaneurysm  is  checked.  This
echnique  has  the  following  advantages:  no  material  is  left
n  the  artery,  it  is  possible  to  repuncture  the  access,  and
either  anticoagulant  nor  antiplatelet  treatment  is  admin-
stered  after  the  procedure.  The  disadvantages  are  the  long
nd  complex  procedure  and  the  need  for  a  contralateral
uncture  with  the  risk  of  complications  at  this  new  site
7].
Treatment  with  covered  stent  (Fig.  5):  the  technique  is
he  same  as  the  one  used  with  the  coils,  with  a  long  intro-
ucer  (5F-6F).  After  visualization  of  the  pseudoaneurysm
eck  by  arteriography,  a  balloon-expandable  monorail  cov-
red  stent  is  placed.  The  advantages  are  the  short  and
elatively  easy  procedure.  The  disadvantages  are  the  con-
ralateral  puncture,  the  risk  of  stent  thrombosis  (need  for  a
ong-term  antiplatelet  treatment)  and  stent  fracture.  In  the
uture,  the  development  of  biodegradable  covered  stents
ould  reduce  these  risks  [11].
ow to prevent bleeding
hecklist before the procedure
oday,  it  is  no  longer  necessary  to  stop  anticoagulant  or
ntiplatelet  treatment  before  most  interventional  radiology
rocedures  (Table  2).  Only  deep  biopsies  or  radiofrequency
blations  as  for  kidney  are  still  considered  procedures  at
isk.  At  most,  anticoagulant  and  antiplatelet  treatment
ill  be  stopped  24  hours  and  5  days,  respectively,  before
rocedures  the  most  at  risk  (kidney  and  deep  biopsy).
lso,  for  some  procedures  such  as  superﬁcial  biopsies
Post-procedure  bleeding  in  interventional  radiology  837
Figure 4. Arteriography showing (a) a pseudoaneurysm of the common femoral artery with a neck (white arrow); catheterization (b)
oils (c
P
T
(
iof the neck with a microcatheter (white arrow); treatment with c
control image (d).
(lymph  nodes),  a  hemostasis  proﬁle  is  no  longer  required
[3].
During the procedureFor  arterial  punctures,  the  main  factor  of  success  and
of  absence  of  complications  lies  with  a  puncture  at  the
‘‘appropriate’’  site.
t
h
p
p
Figure 5. Arteriography (a) showing a pseudoaneurysm of the right s
catheterization of the superﬁcial femoral artery and placement of a 
disappearance of the pseudoaneurysm (c).: white arrow) and disappearance of the pseudoaneurysm on the
uncture of the femoral artery
he  ideal  puncture  site  is  the  common  femoral  artery
Fig.  6),  on  a  scopic  marker  below  the  inguinal  ligament,
n  front  of  the  inferior  edge  of  the  femoral  head.  Above
he  inguinal  ligament,  the  main  risk  is  retroperitoneal
ematoma  (puncture  of  the  external  iliac  artery).  If  the
uncture  site  is  too  low,  there  is  a  risk  of  hematoma  and
seudoaneurysm  (superﬁcial  or  profunda  femoral  artery),
uperﬁcial femoral artery (initial puncture too low) (white arrow);
short covered stent (b) (white arrow); control image shows the
838  J.  Mayer  et  al.
Table  2  Checklist  before  an  interventional  radiology  procedure.
Platelets  PR  (%)  APTT  (LMWH)  INR  (VKA)  Antiplatelet  Anticoagulant
Superﬁcial  biopsy  <  2  <  2  Not  stopped  Skipped  dose
Deep  biopsy  (moderate  risk)  >  50,000  <  1.5 <  1.5 Stopped  5  days
before
Skipped  dose
Kidney  biopsy  (high  risk) >  50,000  >  50  <  1.5 <  1.5 Stop  of  Plavix
(and  aspirin)
5  days  before
Stopped  24  hours
Percutaneous  ablation  >  50,000  >  50  <  1.5 <  1.5 Stop  of  Plavix  Skipped  dose
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[Chemoembolization  >  50,000  >  30  
ince  there  is  no  underlying  bony  structure  from  the  femoral
ead  during  compression  [12].
uncture of the humeral artery
he  access  for  the  humeral  artery  is  located  right  above
he  elbow  (lower  end  of  the  humerus)  and  is  very  nar-
ow  since  it  is  close  to  the  humeral  vein  and  the  median
erve.  The  material  to  be  introduced  may  not  exceed  6F.
he  main  complications  are  hematoma,  pseudoaneurysm,
pasm,  compression  of  nerves  and  vessels,  strokes  (the
atheters  pass  in  front  of  the  supra-aortic  vessels).  To  limit
his  risk,  we  prefer  to  proceed  from  the  left  side  for  proce-
ures  below  the  left  subclavian  artery.
ltrasound-guided puncture
or  both  types  of  punctures,  ultrasound  Doppler  is  rec-
mmended  especially  in  case  of  difﬁcult  access  (in  obese
atients).  Although  ultrasound-guided  Doppler  for  detec-
ion  and  puncture  is  increasingly  used,  there  is  relatively
ittle  information  available.  Systems  where  the  needles  are
ttached  to  the  Doppler  probe  (smart-needle)  are  available;
igure 6. Common femoral artery access: under the inguinal lig-
ment and in front of the femoral head bone. EIA: external iliac
rtery; IEA: inferior epigastric artery; CFA: common femoral artery;
FA: superﬁcial femoral artery; PFA: profunda femoral artery.
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his  makes  the  access  easier  but  does  not  enable  us  to
hange  the  direction  of  the  needle  [12].  A  sterile  probe
leeve  is  used  for  this  procedure.
An  ultrasound-guided  puncture  improves  the  ﬁrst-pass
uccess  rate,  reduces  the  number  of  attempts,  reduces  the
ime  to  access,  and  also  probably  the  risk  of  venipuncture.
he  puncture  rate  of  success  was  not  related  to  the  expertise
f  the  operator  but  the  duration  of  puncture  was  signiﬁ-
antly  reduced.  Finally,  ultrasound-guided  puncture  makes
t  possible  to  reduce  the  number  of  complications  for  5  cm
ematomas  or  larger  (0.6%  with  ultrasound  versus  2.2%  with
adioscopy,  P  =  0.034)  [2,13].
In  fact,  this  technique  allows  us  to  return  to  the  initial
eldinger  technique  with  metallic  needle,  which  recom-
ended  not  to  puncture  the  posterior  wall  of  the  artery
14].
ercutaneous closure devices
hese  devices  are  used  routinely,  although  no  prospective
ulticenter  study  has  assessed  their  efﬁcacy  or  safety.
They  are  used  for  accesses  requiring  material  above  6F,
or  patients  under  anticoagulant  treatment  or  with  impaired
lood  coagulation.
They  have  the  following  advantages:  a  shorter  time  to
emostasis,  shorter  time  to  mobilization,  shorter  time  to
ischarge  (outpatient)  and  greater  comfort  for  the  patient
no  long  manual  compression  nor  compressive  bandage)
4,12].  The  disadvantage  is  their  relatively  high  cost.
Their  use  signiﬁcantly  reduced  the  number  of  hematomas
ver  5  cm  (0.20%  versus  0.46%  for  manual  compression,
 =  0.03)  [4].
Table  3  summarizes  the  different  types  of  closure
evices.  We  present  the  devices  for  access  up  to  6F.  Some
losure  devices  are  autosuture,  used  in  post-closing,  i.e.
laced  at  the  end  of  the  procedure,  up  to  7F,  Proglide
Abbot).  Other  systems  with  extravascular  devices  are  also
vailable,  such  as  Starclose  with  a  nitinol-based  clip  (Abbot)
nd  Exoseal  (Cordis)  with  a  collagen-based  plug.  Finally,
here  are  intra-  and  extravascular  devices  such  as  Angioseal
Saint-Jude  medical),  with  an  intravascular  collagen  anchor
nd  an  extravascular  collagen  plug.  For  this  system,  it  is
ecommended  to  wait  90  days  before  performing  a  new
uncture  at  the  site.In a  multicenter  registry  with  1107  patients,  performed
y  the  CIRSE  between  January  and  August  2009,  a  closure
evice  type  Angioseal  (Saint-Jude  medical)  was  used.  The
eployment  success  rate  was  97%,  with  8.8%  more  failure
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Table  3  Percutaneous  closure  devices.
Auto-suture  With  extravascular  material  With  exo-  and  endovascular  material
Proglide  (Abbot)  Starclose  (Abbot) Angioseal  (St-Jude  medical)
C
A
D
i
a
a
Q
1
2
3Exoseal  (Cordis)
for  the  antegrade  access.  This  closure  device  has  no  market-
ing  authorization  in  France  for  antegrade  access.  Moreover,
obesity,  the  size  of  the  sheath  introducer  and  calciﬁcation
were  not  factors  of  failure.  Time  to  hemostasis  was  reduced
and  patients  could  be  discharged  9  to  24  hours  after  the
procedure  [15].
There  is  no  absolute  contra-indication  to  use  these  sys-
tems,  only  safety  measures.  These  involve  puncture  sites
that  are  too  high  or  too  low,  patients  with  atherosclero-
sis,  arteries  with  a  diameter  smaller  than  4—5  mm  (risk
of  ischemia),  patients  with  diabetes  and  with  immunode-
ﬁciency  (risk  of  infections)  [12].
Post-procedure  complication  was  bleeding  (6%)  which
could  be  managed  by  gentle  compression  in  50%  of  the  cases.
During  follow-up,  complications  were  hematoma  (1%),
embolus  by  material  (1%),  occlusion  or  dissection,  infection
(less  than  1%)  and  thrombosis  at  the  suture  site  [15].
After the procedure
Patients  must  be  monitored  for  6  to  24  hours  after  the  pro-
cedure,  for  pain  and  signs  of  acute  bleeding.
Conclusion
Risk  factors  for  bleeding  during  interventional  radiology
procedures  in  oncology  are  related  to  the  patient,  the  pro-
cedure  and  the  end  organ.
Bleeding  may  occur  at  the  access  (puncture  site)  or  at
the  end  organ  (following  percutaneous  puncture  or  bleeding
of  an  end  artery  during  catheterization).
Bleeding  may  be  prevented  before  the  procedure  by
checking  hemostasis.  During  the  procedure,  bleeding  may
be  prevented  by  ensuring  a  puncture  at  the  appropriate  site
(scopic  or  ultrasound  guidance),  a  possible  use  at  the  end  of
the  procedure  of  curaspon,  biological  glue  or  by  thermo-
coagulation  on  the  needle  track,  by  appropriate  manual
compression  or  the  use  of  a  cutaneous  closure  device.  Fol-
lowing  the  procedure,  patients  must  be  carefully  monitored.
In  case  of  complications,  endovascular  treatment  is  based
on  the  access  (arterial  puncture  or  percutaneous  access),
the  size  of  the  hematoma  and  the  symptoms.
Treatment  may  be  symptomatic  (manual  compression,
monitoring),  endovascular  by  embolization  or  covered  stent
or  surgical.
Take-home  messages
• Bleeding  risk  factors  depend  on  the  patient,  theprocedure  and  the  end  organ.
• The  incidence  of  bleeding  complications  is  similar  for
percutaneous  and  arterial  access  (0.5—4%).
R
1• Anticoagulant  and  antiplatelet  treatments  are
not  systematically  stopped  anymore  before  an
interventional  radiology  procedure.  The  decision  to
stop  depends  on  the  bleeding  risk  and  the  end  organ.
• Bleeding  risk  is  prevented  by  the  accurate
puncture  in  the  common  femoral  artery  under
scopic  or  ultrasound  guidance  and  possibly  with  a
percutaneous  closure  device.
• Interventional  radiology  can  be  used  to  treat
bleeding  complications  by  embolization  or  stenting
depending  on  the  bleeding  site.
linical case
 patient  presents  a  pulsatile  hematoma  of  the  right  Scarpa.
oppler  imaging  shows  a  pseudoaneurysm  of  3.5  cm,  affect-
ng  the  superﬁcial  femoral  artery,  10  days  after  an  arterial
ngioplasty.  The  patient  has  no  deﬁciency  in  red  blood  cells
nd  does  not  suffer  from  pain.
uestions
.  Do  you  believe  that  the  arterial  puncture  was:
a.  Too  high.
b. Too  low.
c.  At  the  appropriate  site.
.  What  are  the  possible  treatments?
a.  Direct  puncture  and  thrombin  injection.
b.  Endovascular  treatment  and  insertion  of  coils  in  the
pseudoaneurysm.
c.  Endovascular  treatment  and  insertion  of  coils  in  the
superﬁcial  femoral  artery.
d.  Endovascular  treatment  and  insertion  of  a covered
stent  in  front  of  the  neck  of  the  pseudoaneurysm.
e.  Endovascular  treatment  and  insertion  of  an  uncov-
ered  stent  in  front  of  the  neck  of  the  pseudoa-
neurysm.
The  patient  refuses  treatment  and  leaves  the  hospital
against  medical  advice.  He  returns  3  days  later.  He  has
deﬁciency  in  red  blood  cells,  fever  and  a  level  of  CRP  at
70  mg/dL.  Scan  imaging  is  performed  (Fig.  7).
.  What  treatments  would  you  recommend?
a.  Monitoring.
b.  Antibiotics  based  on  hemocultures.
c.  Endovascular  treatment.
d.  Direct  puncture  and  thrombin  injection.
e.  Surgery.esponses
.  Response  b.
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1953;39(5):368—76.igure 7. CT scan in coronal plane during the arterial phase shows
 hematoma and a pseudoaneurysm (white arrow) of the left super-
cial femoral artery.
.  Responses  a,  b  and  d.
.  Responses  b  and  e.
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